Science
California employer health premiums will cost as much as a new car in 2027
Employers are bracing for what could be the highest rise in health insurance premiums in 16 years in 2027, driving up the average cost of family coverage in California to more than $30,000 — the price of a new compact car.
Health insurance companies expect the cost of medical services and prescription drugs to soar by 9% in 2027, according to a new survey by PwC, the highest rise the researchers have found since 2011. Insurers use those expected medical costs to calculate the price of premiums in the coming year. Many employers require workers to pay part of that cost.
Experts say the escalating costs of employers’ premiums are reducing workers’ wages and take-home pay, while raising the prices of goods and services in California and across the country.
“It’s going to erode the standard of living for lots of California families,” said Glenn Melnick, a USC professor of healthcare finance.
Melnick said when employers are forced to spend more on health insurance, there is less money available for wages. The skyrocketing premiums, he said, are like a hidden pay cut for working families.
The higher cost also has small-business owners wondering whether they can continue paying for their workers’ health insurance.
Co-owner Camden Avery makes a sale at the Booksmith in San Francisco.
(Josh Edelson / For The Times)
This year, premiums for staff at the Booksmith, an independent bookstore on Haight Street in San Francisco, leaped by 17%, said Christin Evans, the store’s owner. Next year could bring even more pain. The monthly premium for four employees is $3,250.
To try to cope, Evans said, she has reduced staff hours by closing the store earlier.
“We have to absorb it,” she said. “We’re not paying the wages we want to pay or delivering the customer service we’d like to deliver.”
Seventeen million Californians receive health benefits from an employer. Those premiums have been rising faster in California than the national average.
Between 2022 and 2025, the average family premium for employers in the state rose by 24% to $28,397, according to a survey by KFF and the California Healthcare Foundation. That was nearly double the 12.2% increase in consumer prices during those years.
Hospital, pharmaceutical and other medical costs escalated even faster after 2025.
PwC’s annual survey of insurers last year found an expected rise of 8.5% in 2026, which its researchers later revised to 9%.
A key driver of the rising medical costs, according to experts, is prices charged by hospitals. In recent years, some health systems, including UCLA and Cedars-Sinai, have grown larger by buying nearby hospitals and expanding their clinics, becoming more dominant in the community and reducing competition.
Melnick said the expansion of some health systems into giant organizations means that they can “tell insurance companies what the price will be.”
A Cedars-Sinai spokesperson pointed to a 2022 paper that found that for-profit health system prices had escalated faster than those at nonprofit systems like Cedars. The paper was partly funded by Cedars.
“Cedars-Sinai Health System’s growth in recent years has expanded access to the highest levels of patient care and medical innovation across the Los Angeles region,” the spokesperson said.
UCLA did not respond to requests for comment.
Another factor is the rising cost of prescription drugs. Spending on cancer drugs, the most costly category, reached $143 billion in 2025, an annual increase of 12%, the PwC survey found.
The nation’s spending on obesity medicines, including GLP-1 drugs such as Ozempic and Wegovy, soared by 81% last year, PwC said. A 30-day supply of the drugs lists for more than $1,000.
An Ozempic injection pen.
(Christina House / Los Angeles Times)
Gallup said this month that its survey found that 11% of U.S. adults are now taking the GLP-1 drugs for weight loss.
The obesity drug manufacturers say the medicines can reduce medical expenses by preventing other costly conditions such as diabetes and heart disease, but data don’t yet show such reductions, PwC said.
Researchers at the California Healthcare Foundation say a large part of the problem is that hospital operating costs, prescription drug prices and doctor fees have been allowed to grow unchecked for decades.
The foundation estimated in a report last year that 25 cents of every dollar spent in California — more than $73 billion each year — does nothing to help patients. Instead it goes to excessive profits for providers, administrative red tape and other waste, the foundation found.
California employer premiums are expected to rise next year for another reason: Gov. Gavin Newsom and lawmakers agreed in June to raise taxes on the private plans to help pay for the cost of Medi-Cal, which covers the medical costs for the poor, and to help balance the state budget.
The California Assn. of Health Plans said insurers will add the tax to next year’s premiums. The trade group estimates the higher tax will cost each insured person $100 next year or $400 for a family of four.
The higher tax must still be approved by the Trump administration. Republicans in the state Assembly wrote a letter to the administration this month, asking officials to deny the request.
Researchers also expect a jump in premiums for families without employer insurance who purchase policies on state marketplaces such as Covered California. Some of those families faced double-digit increases this year because of rising medical costs and the end of enhanced federal subsidies that Congress had approved as a temporary measure during the pandemic. Almost 400,000 Californians dropped their Obamacare plans this year as prices soared.
To deal with the higher premiums, some employers are changing the design of their health plans to shift more of the cost to workers by raising deductibles and co-pays.
Those higher out-of-pocket costs are just the beginning of the fallout. Twenty-two percent of chief financial officers surveyed by Mercer in February said the high price of health benefits had forced them to stop hiring or led to layoffs. Thirty-six percent of those executives said the rising premium costs have harmed workers’ wages and raises.
Candice Elliott, a human resources consultant in Santa Cruz, said smaller businesses such as restaurants struggle to find ways to cover the higher costs.
Many restaurants, Elliott said, already have a slim margin between their revenues and expenses. When premiums rise, she said, some restaurants have added a fee to the customer bill to help cover workers’ health costs. Others have hiked menu prices.
“That impacts affordability for the consumer,” Elliott said. “It makes inflation greater.”
Some small businesses have moved from so-called silver plans to the lower-priced bronze plans, she said, which cover less of the employee’s monthly premium. “It’s effectively a decrease in pay for the employee,” she said.
Others are hiring employees overseas, Elliott said. “You can pay someone in the global south half of what you pay an American and still afford them a good standard of living and benefits that are unaffordable in the U.S.,” she said.
Melnick, the USC professor, said many workers don’t realize how much they are losing as their employers’ premiums rise. He tells people to look at their W-2 tax form from last year, where employers are required to report the cost of the employee’s premium in box 12, under “Code DD.”
He said USC’s premium for his family of four is $45,000.
“The base is so high that even a small increase has a big impact,” he said. The continuing annual increases, he said, are “bad news for everybody.”
Science
Bonta accuses DuPont of corporate shell game to dodge PFAS cleanup in California
California Atty. Gen. Rob Bonta filed a complaint Thursday alleging that a cohort of the companies that make “forever chemicals” partook in a massive corporate shell game to defraud the state and others.
In an amendment to a 2022 lawsuit filed by Bonta against the makers of these chemicals, the state now alleges that several DuPont spin-off companies — New DuPont, Corteva, Chemours and Qnity Electronics — worked together to create a “fall guy” company designed to take the financial hit stemming from several multibillion-dollar pollution lawsuits while keeping the companies’ most valuable assets out of reach.
“The DuPont Defendants cannot game the system by illegally moving assets out of reach, dodging liabilities for the harm they have caused, and calling it restructuring,” Bonta said in a statement. “I look forward to ensuring that these companies are held accountable for PFAS pollution and that their assets cannot be hidden behind corporate walls while their responsibilities are left behind.”
The Second Amended Complaint, as the new amendment is called, was filed in U.S. District Court for the District of South Carolina on Thursday.
DuPont did not respond to multiple requests for comment.
In 2022, Bonta sued 20 chemical manufacturers, including 3M and DuPont, alleging the companies knew about the dangers of perfluoroalkyl and polyfluoroalkyl substances — or PFAS — when they made and/or sold products containing them. The suit also claims the companies failed to warn the public about the environmental and health risks of those chemicals and in many cases concealed the risks.
That lawsuit remains active and ongoing.
PFAS chemicals are found in a variety of consumer items, including food packaging and cookware, and are linked to cancer and other illnesses and health risks such as developmental defects, infertility and reduced bone density in children.
They are resistant to environmental degradation, according to the Centers for Disease Control and Prevention, the Environmental Protection Agency and hundreds of scientific studies. They have also been found in the bloodstreams of 98% of people tested, as well as in wildlife, fish, water — including rivers, lakes and nearshore waters — and soil.
Data from the State Water Resources Control Board show PFAS chemicals are in drinking, ground and surface waters in the state. They’ve been detected in at least 146 public water systems serving 16 million Californians, as well as in aquifers that provide millions of Californians with water through unregulated domestic wells.
According to a news release from Bonta’s office, the fraudulent DuPont scheme worked like this: By 2013, the original, “Old” DuPont company knew it faced billions of dollars in environmental cleanup costs and legal damages due to its PFAS products. To protect its assets and make itself appealing for a merger with industry giant Dow Chemical, the Old Dupont company initiated a multi-phase restructuring plan, which it called “Project Beta.”
Bonta referred to the original DuPont company as “Old Dupont” and a newer version as “New DuPont” in his filing.
It started with the creation of a company called Chemours, which the Old DuPont company spun off in 2015. The Old DuPont company transferred its PFAS business to this new company and extracted almost $7 billion in cash, stocks and notes from the new company. The new company was also forced to assume all of Old DuPont’s historical PFAS liabilities and sign an agreement to indemnify Old DuPont against them.
Bonta claims this was a sham transaction, leaving Chemours holding the liability bag with no way to pay the environmental debts it would incur should the courts come calling.
Old DuPont merged with Dow Chemical in 2015, and according to Bonta’s claim, the new company, DowDuPont, was again structured in a way that would protect the new company from any remaining PFAS liabilities.
In 2019, the company went through another reshuffling. A “New” Dow was created, which took the materials science assets, as well as a company called Corteva, which took the company’s agricultural businesses. A New DuPont company was also formed.
During this same year, Chemours sued the other DuPont companies, claiming it had been handed a financial time bomb because of the PFAS liability it had been left with. The company alleged the 2015 deal was a sham that set them up for bankruptcy.
In 2021, the companies sat down to resolve the lawsuit. Chemours agreed to drop the lawsuit and waive its right to sue. In exchange, Corteva and New DuPont agreed to split the costs of future PFAS liabilities with Chemours 50/50 — but only up to $4 billion.
Bonta alleges that $4 billion was a gross underestimate of the potential legal damages they were likely to face. The result of the agreement would have capped Corteva and New DuPont’s liability at $2 billion and saddled Chemours with any and everything else — a number he claims is likely to far exceed $2 billion.
Chemours also had insurance policies that would have helped pay for the PFAS lawsuits. However, Bonta alleges that Chemours sold 100% of those insurance payouts back to its sister companies in 2025 for a lump sum of cash that was worth less than half of what the insurance was actually valued at.
By transferring away its best assets (the insurance) while keeping the massive debt, Chemours was hollowed out so it can’t pay its potential creditors, including California.
To further protect their wealth, New DuPont is accused of continuing to chop up its remaining valuable businesses and separating them. For example, the court filing claims they took their profitable electronics business and turned it into a totally separate, independent company called Qnity.
Bonta claims these restructuring moves violate the Uniform Fraudulent Transfer Act and the Uniform Voidable Transactions Act. He is asking the court to stop the companies from selling, spending or moving any more assets or profits that belonged to the original, or Old DuPont company, in order to ensure that California gets its payout if the chemical companies lose the lawsuit.
“Ultimately, the question is whether courts will ‘pierce the corporate veil’ to allow California and other plaintiffs to hold new Dupont and other breakout companies liable,” Albert Lin, a law professor at UC Davis, said in an email.
“Courts are willing to pierce the corporate veil if spinoff companies are created to engage in fraud or wrongdoing or to evade legal obligations,” he said. “Allegations that Dupont undercapitalized or underinsured Chemours and other entities can support veil piercing.”
Science
California’s cyclosporiasis cases are ‘higher than expected,’ but officials aren’t sure why
California is reporting more cases of cyclosporiasis than it would on average for this point in the summer, including two recent cases where residents ate at out-of-state Taco Bell restaurants, according to state health officials and data.
Despite the uptick, officials say California is not included in the cyclosporiasis outbreak that’s hit 15 states, sickening tens of thousands of people with prolonged bouts of diarrhea.
However, officials with the California Department of Public Health told The Times the number of cases is “now higher than what we might expect for this point in the season.”
Latest cyclosporiasis case breakdown in California
California’s cyclosporiasis data now includes probable cases — meaning an ill person showed signs and symptoms of the parasite but the case lacks laboratory confirmation — as well as internationally acquired cases, significantly increasing the state’s case count from previous estimates in June.
Between Jan. 1 and July 15, there were 201 confirmed and probable cyclosporiasis cases in California, the state health department reported.
Of the total number of cases, 39 were domestically acquired, meaning these infected people became ill either in the state or after traveling within the United States.
The rest became ill after traveling internationally, it’s unclear where the sick individuals had traveled to.
“To date, CDPH is aware of 2 cases that traveled to an affected state, ate food at a Taco Bell location and are determined by CDC to be linked to the outbreak,” the agency stated. Because the parasitic disease was contracted from contaminated produce out of state, California is not counted as being a part of the current outbreak.
Of the 201 confirmed and probable cases in California, 11 people were hospitalized, officials said.
There have been no deaths in relation to the California cases of cyclosporiasis.
Why cases in California have gone up
Public health officials are working with local health departments to actively monitor cyclosporiasis cases statewide to determine if there are potential outbreaks here, and identify a possible cause for the increase in cases.
The agency said the high number of cyclosporiasis cases could be attributed to:
- Cyclosporiasis receiving recent, national attention due to the multi-state outbreak. “This has led to increased awareness of the illness in California and nationwide, which has likely led to increased testing for the illness,” the Department of Public Health stated. “We may be identifying more cases than we have in previous years.”
- Overall improvements to the department’s surveillance and data collection methods.
- An increase in cases in travelers to areas with cyclosporiasis outbreaks, whether international or domestic.
What’s happening in the multi-state outbreak
To date, 15 states have reported high numbers of cyclosporiasis cases; the epicenter continues to be in Michigan, whose state public health department has reported more than 12,400 sickened residents, 279 hospitalizations and two deaths.
The two patients who died may have had underlying health conditions that made them particularly vulnerable to the gastrointestinal illness and dehydration that can come with the disease, Michigan public health officials said.
According to the Centers for Disease Control and Prevention, cyclosporiasis is rarely fatal.
On Thursday, Michigan officials said the state’s data now suggests that, “new cyclosporiasis case reports are slowing, including a downward trend in diarrhea-related emergency department visits.”
On average, people exposed to cyclosporiasis — typically through contaminated food or water — start to feel sick seven days after exposure, but symptoms can take up to 14 days to appear.
Given the weeklong average incubation period, Michigan data suggests that:
- Most exposures occurred in late June to early July.
- The majority of the contaminated produce is likely no longer available for consumption.
The outbreak, which began in May, has affected tens of thousands of people who reported feeling ill after eating Taco Bell products with shredded lettuce.
Traceback and outbreak data have linked the shredded iceberg lettuce supplied to the Taco Bell locations to the Salinas-based company Taylor Farms and its Taylor Farms de Mexico facility in Central Mexico.
The company, also known as Taylor Fresh Foods, announced last month it was voluntarily recalling various products including chopped lettuce, shredded lettuce, blends of iceberg, romaine lettuce and salad mixes that were supplied to restaurants and retailers in 27 states.
Since May 1, the CDC has laboratory-confirmed 10,468 domestic cases of cyclosporiasis and is aware of more than 12,255 additional cases that have yet to be laboratory confirmed.
Officials say the true number of cases is likely higher because some people recover without medical care and are not tested for the parasite.
Science
Tiny toad, big discovery: New ice age amphibian found in La Brea Tar Pits collection
Researchers in Los Angeles have made a ribbiting new discovery at the La Brea Tar Pits and Museum — an extinct amphibian from the ice age.
The spadefoot toad, or Spea labreae, is one of only two ice age amphibians to have been found in the U.S. The other is an extinct species of tree frog in Florida, known as Hyla baderi, according to the museum.
“While the toad may be much smaller than the mammoths and saber-toothed cats that made the Tar Pits famous, this discovery has a big impact on our understanding of the climate at the end of the last ice age,” the news release read.
The discovery of the spadefoot toad was made two years ago but published recently in the Journal of Vertebrate Paleontology and marks one of several discoveries made at the Samuel Oschin Global Center for Ice Age Research at the La Brea Tar Pits, where the museum is undergoing renovation.
Unearthing the spadefoot toad wasn’t the result of a targeted search — it happened by accident, much like many of history’s greatest finds.
Dr. Alberto Cruz, the lead author, was reviewing the rarely studied collections of amphibians and reptiles as a postdoctoral fellow at the La Brea Tar Pits when he noticed an amphibian that looked different from the others.
At first glance, he thought he was looking at a specimen that had been sick or injured rather than a new species. Upon closer inspection, he realized that wasn’t the case.
This incomplete sacro-urostyle bone (base of the spine that connects to the hips) is the holotype specimen used to describe the new species, Spea labreae.
(La Brea Tar Pits)
To identify the spadefoot toad, Cruz said he examined the bones of amphibians found at the Tar Pits, a collection that hadn’t been analyzed in nearly 30 years. He then compared the collection with the 80 specimens at the Herpetology Collection at the Los Angeles County Natural History Museum and the Museum of Vertebrate Zoology at the University of Berkeley.
“I thought: ‘Oh my gosh, this is a new species,’” he said. “This material is originally from the 1950s, but when you study it again, you can find gold in these specimens. It’s very cool.”
Researchers say amphibians provide a window into the past because they don’t travel far during their lifetimes and are sensitive to climate change. When their fossils are discovered, it helps scientists piece together how local environments changed over time.
“If you change the environment, you change the vegetation, the climate is warmer or colder, it affects these animals directly,” Cruz said.
The miracle behind Cruz’s discovery is that amphibians such as frogs, toads and salamanders rarely make it into the fossil records because of their fragile skeletons.
Emily Lindsey, curator and excavation site director at the La Brea Tar Pits’ center, said the discovery of the ice age toad is an example of the ongoing discoveries being made at the museum.
“There’s definitely more to come,” she said.
Also detailed in the Journal of Vertebrate Paleontology is the first record of another amphibian: the Mexican burrowing toad —Rhinophrynus. The species, which still exists, once inhabited the Southwestern region including Los Angeles. Researchers note that its closest known population is now roughly 1,550 miles away in southern Mexico.
-
Dallas, TX3 minutes agoFC Dallas vs Chivas: Highlights and stats
-
Miami, FL9 minutes agoMiami coffee shop providing employment for adults with disabilities celebrates first anniversary – WSVN 7News | Miami News, Weather, Sports | Fort Lauderdale
-
Boston, MA15 minutes agoAnother Red Sox player sidelined as clubhouse bug makes its way around
-
Denver, CO21 minutes ago
Ranking the Broncos’ most deserving Hall of Fame candidates
-
Seattle, WA27 minutes agoWhere to watch Tampa Bay Rays vs Seattle Mariners: TV channel, start time, streaming for Aug. 9
-
San Diego, CA33 minutes agoWhat should become of the Lake Hodges Dam? As San Diego studies its options, local leaders worry about lake
-
Milwaukee, WI39 minutes agoMilwaukee Police investigating two fatal shootings, one non-fatal shooting
-
Atlanta, GA45 minutes agoAmerica250 on ‘America’s Field Trip’ youth contest in Atlanta